Gregory Austin Ciongoli is Director at REGENXBIO Inc. (RGNX). They have made 1 open-market trade across 1 company since 2026, most recently 2026-08-27.
CIK 0002023732
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $949K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZYME | 488,500 | $12.2M |
| RGNX | 118,035 | $818K |
| ATRA | 12,000 | $114K |
| Total | $13.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGNX | BUY | 2026-08-26 | 2026-08-27 | $9.25 | $949K | -13.6% | -25.8% | — |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.